D. Scott Davis - 25 Apr 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: Director
Issuer ticker: JNJ
Reported as of: 25 Apr 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Oct 2024, 16:39:05 UTC
Prior SEC filing: 17 Apr 2024
Next SEC filing: 16 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Laura McFalls, as attorney-in-fact for D. Scott Davis

Key filing fact

D. Scott Davis filed Form 4 for JOHNSON & JOHNSON (JNJ) on 15 Oct 2024.

Key facts

This page summarizes D. Scott Davis's Form 4 filing for JOHNSON & JOHNSON (JNJ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Oct 2024, 16:39.

Change

Previous filing in this sequence was filed on 17 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Deferred Share Units

Award

Transaction value: $0
Shares: +1,386
Change %: +9.7%
Price: $0.000000
Shares after: 15,604
Date: 25 Apr 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,386
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

D. Scott Davis is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

Footnote F2

Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.